Mouwasat Trading: Comprehensive Guide to Mouwasat Stock in Saudi Market

Mouwasat Medical Services Company was established by a group of local investors with the aim of developing specialized medical infrastructure in the Kingdom of Saudi Arabia. Mouwasat focuses on establishing and operating hospitals and healthcare facilities, and today it is one of the leading names in the private healthcare sector. Its projects are distributed across several major cities such as Yanbu and Jeddah, and it works to meet the increasing demand for high-quality medical services. The company is characterized by adopting modern operating models, with a focus on advanced medical specialties and comprehensive care. Mouwasat's listing on the Saudi financial market reflects investors' confidence in the private healthcare sector and its future role within Vision 2030. The company is seen as one of the cornerstones of healthcare transformation by providing innovative medical solutions and expanding services to multiple regions in the Kingdom.

Mouwasat Medical Services stock is traded on the main market of Tadawul under the symbol 4002. The company holds a strong position within the healthcare services sector and is classified as relatively large-cap compared to some emerging companies. The main market (Tadawul) provides a high level of transparency and disclosure, enhancing investor confidence and making Mouwasat stock a focal point for those following developments in the private healthcare sector. The stock's performance and financial indicators can be monitored through its official stock page: /stocks/4002/. This symbol facilitates tracking company news, accessing official disclosures, and reading financial analyses issued by the Saudi financial market.

During 2024 and 2025, Mouwasat focused on expanding its medical projects, particularly the hospitals in Yanbu and Jeddah. These projects contributed to an increase in total assets and a gradual rise in operating revenues. In 2024, the company began generating revenues from some existing services and hospitals, while 2025 saw the completion of construction work for the Yanbu hospital and the start of trial operations. These developments significantly reflected on financial indicators, with total assets increasing, while net profit remained limited initially due to substantial investments. As trial operations commenced, operating profits improved, showing good growth compared to what was planned. It is noteworthy that the company is still in the process of establishing its financial stability, with expectations of further improvement as new projects are fully completed and operational in the coming years.

The evaluation of Mouwasat stock relies on several key financial indicators:
- Market Price: By the end of 2025, the stock price ranged between 11 and 12 Saudi Riyals, with the need to review updated prices through official market sources.
- Market Capitalization: Calculated by multiplying the number of shares by the stock price, it reached tens of billions of Saudi Riyals, reflecting the company's substantial capital compared to its competitors in the healthcare sector.
- Price-to-Earnings Ratio (P/E): Due to the nascent operations and only initial profits, the P/E ratio was high (often ranging between 50 and 100 or more), reflecting the challenges associated with achieving quick returns in medical infrastructure projects.
- Dividend Yield: By the end of 2025, the company had not announced any cash distributions, as Mouwasat's management preferred to reinvest profits to support future expansion. Distributions are often announced after stabilizing operational profits.
These indicators help in understanding the company's performance and financial trends, with the importance of reviewing official sources for periodically updated data.

The healthcare sector in the Kingdom of Saudi Arabia is witnessing rapid growth, driven by increased demand for medical care, demographic changes, and support from Vision 2030. The Saudi government aims to enhance the private sector's contribution to healthcare services, creating a competitive and encouraging investment environment. In this context, companies like Mouwasat have significant expansion opportunities, especially with the ongoing need for modern hospitals and specialized treatment centers. However, the sector faces several challenges, including high operating costs, a shortage of qualified medical personnel, and increasing competition from both public and private hospitals. Additionally, mandatory health insurance applications sometimes affect profit margins. Despite these challenges, the healthcare sector is viewed as one of the most promising sectors in the Saudi stock market in the long term, making continuous monitoring of company performance essential for investors and stakeholders.

Mouwasat competes with several companies in the Saudi healthcare sector, including both listed and private companies. Among the prominent competitors are companies managing specialized hospitals in major cities, such as the Saudi Hospitals Company, the International Medical Center, and Al-Madina Medical Services Company. Public hospitals also receive significant government support, making competition for attracting patients and medical personnel intense. Mouwasat distinguishes itself by focusing on establishing and operating hospitals in specific geographic areas (such as Yanbu and Jeddah), in addition to relying on modern business models and advanced medical technologies. This approach allows it to meet the needs of a wide population segment and enhances its growth potential amid competition. However, the company's distinctiveness remains contingent on its ability to continue expanding and achieving strong operational results compared to its competitors.

In 2025, Mouwasat announced the completion of construction work at the Yanbu hospital and the commencement of trial operations, a significant achievement that strengthens the company's presence in the western region of the Kingdom. The company is also continuing work on the Jeddah hospital project, expected to open in the coming years, in addition to exploring opportunities to enter new markets within the Kingdom and possibly the Gulf. These expansions reflect Mouwasat's commitment to a growth strategy and expanding its customer base. Company data indicates that financial performance has begun to improve as new hospitals enter the operational phase, supporting its aspirations for financial stability and sustainable growth in the coming years.

Mouwasat stock has witnessed active trading in some sessions, especially when positive developments in its projects were announced. According to market reports, over 96 companies recorded trades higher than the 3-month average in specific sessions, reflecting investor interest in growing stocks in key sectors such as healthcare. Although Mouwasat's liquidity is lower compared to major listed companies in the Saudi market (such as Aramco or Al-Rajhi), it is considered good within the medium and small company category in the healthcare sector. This trend highlights the importance of monitoring liquidity and trading volumes as part of the comprehensive analysis of stocks listed on the Saudi financial market.

Mouwasat stock falls into the medium to high-risk category in the short term, due to the substantial investments required to establish and operate hospitals. Profits may be affected initially due to high costs and the long payback period. However, the success of new projects and achieving high occupancy rates may provide the stock with good returns in the long term. Investment in private healthcare sector stocks should always be viewed as a long-term investment based on market growth and the development of medical infrastructure. It is essential to always study the risks associated with the sector and regulatory changes, in addition to periodically evaluating the company's financial performance.

Mouwasat continues to implement ambitious expansion plans, exploring opportunities to launch new healthcare projects in other Saudi cities, as well as seeking strategic partnerships with medical and governmental entities. The company is expected to focus on fully operating the Jeddah hospital in 2026, increasing the capacity of the Yanbu hospital, and exploring possibilities to enter specialized medical sectors such as day surgeries or advanced diagnostic centers. Through these strategies, Mouwasat aims to enhance its competitive position and increase its operating revenues while maintaining the quality of medical services provided to its clients.

Mouwasat places great importance on employing qualified medical personnel and utilizing the latest technologies in managing and operating hospitals. The company focuses on continuous training programs for doctors and nursing staff, in addition to investing in modern medical devices and health information systems. The ability to attract medical talents is one of the key success factors in the private healthcare sector. Mouwasat also enhances its digital ecosystem by developing patient management systems and electronic medical records, contributing to improving the quality of medical care and increasing operational efficiency.

To obtain accurate and updated information about Mouwasat stock, it is always recommended to follow official sources such as the official website of the Saudi financial market (Tadawul), where a dedicated page for Mouwasat stock under symbol 4002 is available. The Argaam website also provides detailed financial reports and periodic updates on the company's results and news. Additionally, one can benefit from the company's announcements published on social media platforms and Saudi economic newspapers. These sources represent the primary reference for tracking stock developments, official disclosures, and quarterly and annual reports issued by the company.